Nextage Therapeutics Ltd

TA:NXTG Israel Drug Manufacturers - Specialty & Generic

Market Cap

$5.79 Million

ILA2.16 Billion ILA

Market Cap Rank

#41737 Global

#389 in Israel

Share Price

ILA64.10

Change (1 day)

-17.72%

52-Week Range

ILA64.10 - ILA111.70

All Time High

ILA5080.00

Nextage Therapeutics Ltd - Asset Resilience Ratio

Latest as of December 2021: 2.32%

Nextage Therapeutics Ltd (NXTG) has an Asset Resilience Ratio of 2.32% as of December 2021. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

ILA99.00K

Cash + Short-term Investments

Total Assets

ILA4.27 Million

All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2017–2021)

This chart shows how Nextage Therapeutics Ltd's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.

Liquid Assets Composition Over Time

This chart breaks down Nextage Therapeutics Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	ILA0.00	0%
Short-term Investments	ILA99.00K	2.32%
Total Liquid Assets	ILA99.00K	2.32%

Asset Resilience Insights

Limited Liquidity: Nextage Therapeutics Ltd maintains only 2.32% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.